NO20004405D0 - Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati - Google Patents

Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati

Info

Publication number
NO20004405D0
NO20004405D0 NO20004405A NO20004405A NO20004405D0 NO 20004405 D0 NO20004405 D0 NO 20004405D0 NO 20004405 A NO20004405 A NO 20004405A NO 20004405 A NO20004405 A NO 20004405A NO 20004405 D0 NO20004405 D0 NO 20004405D0
Authority
NO
Norway
Prior art keywords
ocular
prophylaxis
therapy
pharmaceutical composition
diseases associated
Prior art date
Application number
NO20004405A
Other languages
English (en)
Other versions
NO20004405L (no
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO20004405D0 publication Critical patent/NO20004405D0/no
Publication of NO20004405L publication Critical patent/NO20004405L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20004405A 1998-03-05 2000-09-04 Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati NO20004405L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5362498 1998-03-05
PCT/JP1999/001031 WO1999044624A2 (en) 1998-03-05 1999-03-03 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy

Publications (2)

Publication Number Publication Date
NO20004405D0 true NO20004405D0 (no) 2000-09-04
NO20004405L NO20004405L (no) 2000-11-03

Family

ID=12948075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004405A NO20004405L (no) 1998-03-05 2000-09-04 Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati

Country Status (17)

Country Link
US (1) US6423691B1 (no)
EP (2) EP1504760B1 (no)
JP (1) JP4422894B2 (no)
KR (1) KR20010041605A (no)
CN (1) CN1298304A (no)
AR (1) AR018576A1 (no)
AT (2) ATE296635T1 (no)
AU (1) AU2745599A (no)
BR (1) BR9908566A (no)
CA (1) CA2322854A1 (no)
DE (2) DE69925578T2 (no)
HU (1) HUP0101733A3 (no)
ID (1) ID27083A (no)
NO (1) NO20004405L (no)
PL (1) PL343412A1 (no)
WO (1) WO1999044624A2 (no)
ZA (1) ZA991749B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002034252A1 (ja) * 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
WO2004009537A1 (ja) * 2002-07-22 2004-01-29 Senju Pharmaceutical Co., Ltd. 新規α−ケトアミド誘導体およびその用途
EP1543371B1 (en) 2002-09-19 2009-12-23 Koninklijke Philips Electronics N.V. Electrowetting optical switch
WO2004060373A1 (ja) * 2002-12-27 2004-07-22 Santen Pharmaceutical Co., Ltd. 滲出型加齢黄斑変性治療剤
RU2316295C1 (ru) * 2006-03-16 2008-02-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию Способ консервативного лечения гемангиомы придаточного аппарата глаза и орбиты у детей
AU2010253770B9 (en) 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
US20120065793A1 (en) 2010-02-25 2012-03-15 Kaji Mitsuru Demand and supply control apparatus, demand and supply control method, and program
RU2441631C2 (ru) * 2010-04-07 2012-02-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт глазных болезней РАМН (НИИГБ РАМН) Способ поэтапного поступательного лазерного лечения ретиношизиса
WO2012008159A1 (en) 2010-07-14 2012-01-19 Senju Pharmaceutical Co., Ltd. Solid dispersion of alfa-ketoamide derivatives
RU2452436C1 (ru) * 2011-01-31 2012-06-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения атрофии зрительного нерва сосудистого генеза
SG10202103834VA (en) * 2014-02-21 2021-05-28 Sumitomo Dainippon Pharma Co Ltd Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
US10449234B2 (en) 2015-09-11 2019-10-22 The Schepens Eye Research Institute, Inc. Compositions and methods for prevention and treatment of corneal haze and scarring
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
JP2848232B2 (ja) * 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
EP0731107A1 (en) * 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Production of aldehyde derivatives
ES2193615T3 (es) * 1995-10-25 2003-11-01 Senju Pharma Co .nhibidor de la angiogenesis.
DE69637307T2 (de) 1995-11-28 2008-02-28 Cephalon, Inc. Aus d-aminosäuren abgeleitete cystein-und serinproteasehemmer
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung

Also Published As

Publication number Publication date
JP2002505297A (ja) 2002-02-19
NO20004405L (no) 2000-11-03
PL343412A1 (en) 2001-08-13
ATE296635T1 (de) 2005-06-15
WO1999044624A3 (en) 1999-10-21
DE69939075D1 (de) 2008-08-21
ID27083A (id) 2001-02-22
CN1298304A (zh) 2001-06-06
EP1058553B1 (en) 2005-06-01
WO1999044624A2 (en) 1999-09-10
HUP0101733A3 (en) 2001-12-28
ZA991749B (en) 1999-09-16
BR9908566A (pt) 2000-11-21
KR20010041605A (ko) 2001-05-25
CA2322854A1 (en) 1999-09-10
EP1058553A2 (en) 2000-12-13
US6423691B1 (en) 2002-07-23
ATE400277T1 (de) 2008-07-15
AU2745599A (en) 1999-09-20
JP4422894B2 (ja) 2010-02-24
DE69925578D1 (de) 2005-07-07
HUP0101733A2 (hu) 2001-11-28
EP1504760A1 (en) 2005-02-09
AR018576A1 (es) 2001-11-28
DE69925578T2 (de) 2006-04-27
EP1504760B1 (en) 2008-07-09

Similar Documents

Publication Publication Date Title
DK1041990T3 (da) Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
NO994014L (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
IL141429A0 (en) Compositions and methods for treatment of mitochondrial diseases
HUP0600140A2 (en) Prostaglandine derivatives for the treatment of diseases with bone mass loss having ep4 agonist activity and pharmaceutical compositions thereof
HUP0201463A3 (en) Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect and their use
NO20005387L (no) 3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommer
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
NO914315D0 (no) Fremgangsmaate og sammensetning for surgjoering av underjordiske formasjoner
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
PL343412A1 (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy
NO931186L (no) Terapeutisk aktive imidazolderivater, fremgangsmaate for deres fremstilling og anvendelse derav
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
AU3607597A (en) Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
NO964330L (no) Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse derav
DE59309732D1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen
HUP0204180A3 (en) External composition and its use for treating of allergic skin diseases
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
NO20003881D0 (no) Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber
HUP0301971A3 (en) Uses of thaliporphine or its derivatives for producing pharmaceutical compositions suitable for treating cardiac diseases and the compounds
HUP9800835A3 (en) Pharmaceutical composition for treatment of diseases of honey-bees caused by ascophaera apis
NO20004679D0 (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application